$2.26T
Total marketcap
$126.59B
Total volume
BTC 49.79%     ETH 15.71%
Dominance

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited GU5.F Stock

2.2 EUR {{ price }} -0.900900% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
5.69B EUR
LOW - HIGH [24H]
2.2 - 2.2 EUR
VOLUME [24H]
300 EUR
{{ volume }}
P/E Ratio
6.87
Earnings per share
0.32 EUR

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Price Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited GU5.F Financial and Trading Overview

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock price 2.2 EUR
Previous Close 2.74 EUR
Open 2.7 EUR
Bid 2.7 EUR x 200000
Ask 2.92 EUR x 190000
Day's Range 2.7 - 2.7 EUR
52 Week Range 2.1 - 3.14 EUR
Volume 1.61K EUR
Avg. Volume 0 EUR
Market Cap 6.83B EUR
Beta (5Y Monthly) 0.744827
PE Ratio (TTM) 9
EPS (TTM) 0.32 EUR
Forward Dividend & Yield 0.1 (3.40%)
Ex-Dividend Date June 14, 2023
1y Target Est N/A

GU5.F Valuation Measures

Enterprise Value -1356285952 EUR
Trailing P/E 9
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.09499413
Price/Book (mrq) 0.12922989
Enterprise Value/Revenue -0.019
Enterprise Value/EBITDA -0.296

Trading Information

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock Price History

Beta (5Y Monthly) 0.744827
52-Week Change 2.32%
S&P500 52-Week Change 20.43%
52 Week High 3.14 EUR
52 Week Low 2.1 EUR
50-Day Moving Average 2.85 EUR
200-Day Moving Average 2.6 EUR

GU5.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 219.9M
Float 850.76M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 31.12%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.732
Trailing Annual Dividend Yield 26.71%
5 Year Average Dividend Yield 279.00%
Payout Ratio 0.2747
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 5.66%
Operating Margin (ttm) 5.70%
Gross Margin 18.69%
EBITDA Margin 6.37%

Management Effectiveness

Return on Assets (ttm) 3.64%
Return on Equity (ttm) 12.58%

Income Statement

Revenue (ttm) 71.88B EUR
Revenue Per Share (ttm) 44.21 EUR
Quarterly Revenue Growth (yoy) 5.29%
Gross Profit (ttm) 13.24B EUR
EBITDA 4.58B EUR
Net Income Avi to Common (ttm) 4.07B EUR
Diluted EPS (ttm) 0.3
Quarterly Earnings Growth (yoy) 5.70%

Balance Sheet

Total Cash (mrq) 20.3B EUR
Total Cash Per Share (mrq) 12.49 EUR
Total Debt (mrq) 13.02B EUR
Total Debt/Equity (mrq) 36.58 EUR
Current Ratio (mrq) 1.686
Book Value Per Share (mrq) 20.893

Cash Flow Statement

Operating Cash Flow (ttm) 3.24B EUR
Levered Free Cash Flow (ttm) -1321152128 EUR

Profile of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Country Germany
State N/A
City Guangzhou
Address No. 45, Shamian North Street
ZIP 510130
Phone 86 20 6628 1011
Website https://www.gybys.com.cn
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 24249

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern Medicine, Great Commerce, Great Health, and Great Medical Care. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, and medical devices; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, Guiling jellies, etc. In addition, the company invests in health industry, such as medical services, health management, health care, elderly care, etc.; and provides business and advertising agency services. It operates retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Q&A For Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock

What is a current GU5.F stock price?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited GU5.F stock price today per share is 2.2 EUR.

How to purchase Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock?

You can buy GU5.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited?

The stock symbol or ticker of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is GU5.F.

Which industry does the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited company belong to?

The Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited industry is Drug Manufacturers-Specialty & Generic.

How many shares does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited have in circulation?

The max supply of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited shares is 2.58B.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Price to Earnings Ratio (PE Ratio)?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited PE Ratio is 6.87500050 now.

What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited earnings per share over the trailing 12 months (TTM)?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited EPS is 0.32 EUR over the trailing 12 months.

Which sector does the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited company belong to?

The Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited sector is Healthcare.